{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:13:59Z","timestamp":1791324839562,"version":"4.3.1"},"reference-count":83,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2016,3,23]],"date-time":"2016-03-23T00:00:00Z","timestamp":1458691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Aspirin (ASA) and non-steroidal anti-inflammatory drugs (NSAIDs) are a mainstay of therapy for the treatment of idiopathic pericarditis (IP). A comprehensive review consisting of pertinent clinical literature, pharmacokinetic, and pharmacodynamic considerations, has not been released in recent years. This review will facilitate the clinician\u2019s understanding of pharmacotherapeutic considerations for using ASA\/NSAIDs to treat IP. Data were compiled using clinical literature consisting of case reports, cohort data, retrospective and prospective studies, and manufacturer package inserts. ASA, ibuprofen, indometacin, and ketorolac relatively have the most evidence in the treatment of IP, provide symptomatic relief of IP, and should be tapered accordingly. ASA is the drug of choice in patients with coronary artery disease (CAD), heart failure (HF), or renal disease, but should be avoided in patients with asthma and nasal polyps, who are na\u00efve to ASA therapy. Ibuprofen is an inexpensive and relatively accessible option in patients who do not have concomitant CAD, HF, or renal disease. Indometacin is not available over-the-counter in the USA, and has a relatively higher incidence of central nervous system (CNS) adverse effects. Ketorolac is an intravenous option; however, clinicians must be mindful of the maximum dose that can be administered. While ASA\/NSAIDs do not ameliorate the disease process of IP, they are part of first-line therapy (along with colchicine), for preventing recurrence of IP. ASA\/NSAID choice should be dictated by comorbid conditions, tolerability, and adverse effects. Additionally, the clinician should be mindful of considerations such as tapering, high-sensitivity CRP monitoring, bleeding risk, and contraindications to ASA\/NSAID therapy.<\/jats:p>","DOI":"10.3390\/ph9020017","type":"journal-article","created":{"date-parts":[[2016,3,23]],"date-time":"2016-03-23T11:40:54Z","timestamp":1458733254000},"page":"17","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Non-Steroidal Anti-Inflammatory Drugs and Aspirin Therapy for the Treatment of Acute and Recurrent Idiopathic Pericarditis"],"prefix":"10.3390","volume":"9","author":[{"given":"Nicholas","family":"Schwier","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Clinical and Administrative Sciences, College of Pharmacy, University of Oklahoma, 1110 N. Stonewall Avenue, CPB 214, Oklahoma City, OK 73117, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Tran","sequence":"additional","affiliation":[{"name":"Department of Cardiology, College of Medicine, University of Oklahoma, 825 N.E. 10th Street, 2E, Oklahoma City, OK 74104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,3,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1056\/NEJMcp1404070","article-title":"Clinical practice. Acute pericarditis","volume":"371","author":"LeWinter","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","article-title":"2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)","volume":"36","author":"Adler","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1161\/CIRCULATIONAHA.114.010376","article-title":"Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis","volume":"130","author":"Kyto","year":"2014","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4065\/mcp.2010.0046","article-title":"Pericardial disease: Diagnosis and management","volume":"85","author":"Khandaker","year":"2010","journal-title":"Mayo Clin. Proc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrcardio.2009.185","article-title":"Diagnosis and management of pericardial diseases","volume":"6","author":"Imazio","year":"2009","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijcard.2008.05.020","article-title":"Antinuclear antibodies in recurrent idiopathic pericarditis: Prevalence and clinical significance","volume":"136","author":"Imazio","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1586\/1744666X.2014.965150","article-title":"Idiopathic recurrent pericarditis as an immune-mediated disease: Current insights into pathogenesis and emerging treatment options","volume":"10","author":"Imazio","year":"2014","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/hrt.2009.187138","article-title":"Anti-heart and anti-intercalated disk autoantibodies: Evidence for autoimmunity in idiopathic recurrent acute pericarditis","volume":"96","author":"Caforio","year":"2010","journal-title":"Heart"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/0002-8703(81)90610-4","article-title":"Therapy of symptomatic pericarditis after myocardial infarction: Retrospective and prospective studies of aspirin, indomethacin, prednisone, and spontaneous resolution","volume":"101","author":"Berman","year":"1981","journal-title":"Am. Heart J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/01.CRD.0000077500.07781.C9","article-title":"Nonsteroidal anti-inflammatory drugs in the treatment of pericarditis","volume":"11","author":"Schifferdecker","year":"2003","journal-title":"Cardiol. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003495-199600525-00004","article-title":"The mechanisms of action of NSAIDs in analgesia","volume":"52","author":"Cashman","year":"1996","journal-title":"Drugs"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1476-5381.1981.tb10464.x","article-title":"Stimulation of prostacyclin release from the epicardium of anaesthetized dogs","volume":"74","author":"Dusting","year":"1981","journal-title":"Br. J. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1161\/CIRCULATIONAHA.110.986372","article-title":"Prevalence of C-reactive protein elevation and time course of normalization in acute pericarditis: Implications for the diagnosis, therapy, and prognosis of pericarditis","volume":"123","author":"Imazio","year":"2011","journal-title":"Circulation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: A critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/phar.1527","article-title":"Pharmacotherapy update of acute idiopathic pericarditis","volume":"35","author":"Schwier","year":"2015","journal-title":"Pharmacotherapy"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1542\/peds.62.5S.867","article-title":"Clinical pharmacokinetics of aspirin","volume":"62","author":"Levy","year":"1978","journal-title":"Pediatrics"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.105.542738","article-title":"Colchicine in addition to conventional therapy for acute pericarditis: Results of the COlchicine for acute PEricarditis (COPE) trial","volume":"112","author":"Imazio","year":"2005","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa1208536","article-title":"A randomized trial of colchicine for acute pericarditis","volume":"369","author":"Imazio","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/archinte.165.17.1987","article-title":"Colchicine as first-choice therapy for recurrent pericarditis: Results of the CORE (COlchicine for REcurrent pericarditis) trial","volume":"165","author":"Imazio","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-155-7-201110040-00359","article-title":"Colchicine for recurrent pericarditis (CORP): A randomized trial","volume":"155","author":"Imazio","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/S0140-6736(13)62709-9","article-title":"Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): A multicentre, double-blind, placebo-controlled, randomised trial","volume":"383","author":"Imazio","year":"2014","journal-title":"Lancet"},{"key":"ref_22","first-page":"f3195","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs)","volume":"346","author":"Day","year":"2013","journal-title":"BMJ"},{"key":"ref_23","first-page":"1131","article-title":"The double-edged sword of COX-2 selective NSAIDs","volume":"167","author":"Wright","year":"2002","journal-title":"CMAJ"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00003088-199834020-00002","article-title":"Clinical pharmacokinetics of ibuprofen. The first 30 years","volume":"34","author":"Davies","year":"1998","journal-title":"Clin. Pharmacokinet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ijcp.12053","article-title":"Ibuprofen blood plasma levels and onset of analgesia","volume":"67","author":"Mehlisch","year":"2013","journal-title":"Int. J. Clin. Pract."},{"key":"ref_26","first-page":"896","article-title":"Safety of ibuprofen for acute myocardial infarction pericarditis","volume":"57","author":"Spodick","year":"1986","journal-title":"Am. J. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"928","DOI":"10.2459\/JCM.0b013e32833e5788","article-title":"Triage and management of pericardial effusion","volume":"11","author":"Imazio","year":"2010","journal-title":"J. Cardiovasc. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijcard.2006.07.100","article-title":"Triage and management of acute pericarditis","volume":"118","author":"Imazio","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/CS20070092","article-title":"Combination of indomethacin and statin compared with indomethacin and placebo in patients with a first episode of acute pericarditis: Preliminary findings","volume":"113","author":"Cannizzaro","year":"2007","journal-title":"Clin. Sci."},{"key":"ref_30","unstructured":"Morgantown, W.V. (2013). Ketorolac, Prescribing Information, Mylan Pharmaceuticals Inc."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/j.1875-9114.1986.tb03485.x","article-title":"Comparison of intramuscular ketorolac tromethamine and morphine sulfate for analgesia of pain after major surgery","volume":"6","author":"Yee","year":"1986","journal-title":"Pharmacotherapy"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/0002-8703(93)91032-A","article-title":"Rapid resolution of symptomatic acute pericarditis with ketorolac tromethamine: A parenteral nonsteroidal antiinflammatory agent","volume":"125","author":"Arunasalam","year":"1993","journal-title":"Am. Heart J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/eurheartj\/ehn608","article-title":"Colchicine for pericarditis: Hype or hope?","volume":"30","author":"Imazio","year":"2009","journal-title":"Eur. Heart J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10741-012-9328-9","article-title":"Treatment with aspirin, NSAID, corticosteroids, and colchicine in acute and recurrent pericarditis","volume":"18","author":"Imazio","year":"2013","journal-title":"Heart Fail. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.recesp.2013.08.016","article-title":"Treatment of recurrent pericarditis","volume":"67","author":"Imazio","year":"2014","journal-title":"Rev. Esp. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"712","DOI":"10.2459\/JCM.0b013e3283340b97","article-title":"Medical therapy of pericardial diseases: Part I: Idiopathic and infectious pericarditis","volume":"11","author":"Imazio","year":"2010","journal-title":"J. Cardiovasc. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0889-8553(05)70247-8","article-title":"NSAIDs, gastrointestinal injury, and cytoprotection","volume":"25","author":"Scheiman","year":"1996","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.jacc.2008.08.002","article-title":"ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents","volume":"52","author":"Bhatt","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/archinte.160.14.2093","article-title":"Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding\/perforation: An overview of epidemiologic studies published in the 1990s","volume":"160","author":"Rodriguez","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa012877","article-title":"Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use","volume":"346","author":"Lai","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Mo, C., Sun, G., Wang, Y.Z., Lu, M.L., and Yang, Y.S. (2015). PPI versus histamine H2 receptor antagonists for prevention of upper gastrointestinal injury associated with low-dose aspirin: Systematic review and meta-analysis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0131558"},{"key":"ref_42","first-page":"728","article-title":"Guidelines for prevention of NSAID-related ulcer complications","volume":"104","author":"Lanza","year":"2009","journal-title":"Am. J. Gastroenterol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM199803123381105","article-title":"Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group","volume":"338","author":"Hawkey","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"72S","DOI":"10.1016\/S0002-9343(99)00370-8","article-title":"General tolerability and use of nonsteroidal anti-inflammatory drugs","volume":"107","author":"Mandell","year":"1999","journal-title":"Am. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.3748\/wjg.v16.i45.5651","article-title":"Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage?","volume":"16","author":"Bessone","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.dld.2009.06.009","article-title":"Clinical course and outcomes of drug-induced liver injury: Nimesulide as the first implicated medication","volume":"42","author":"Licata","year":"2010","journal-title":"Dig. Liver Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.14309\/crj.2014.81","article-title":"Aspirin-induced acute liver injury","volume":"2","author":"Laster","year":"2014","journal-title":"ACG Case Rep. J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/0002-9149(84)90038-9","article-title":"Morphologic and functional effects of piroxicam on myocardial scar formation after coronary occlusion in dogs","volume":"53","author":"Hammerman","year":"1984","journal-title":"Am. J. Cardiol."},{"key":"ref_49","first-page":"211","article-title":"Myocardial infarct expansion during indomethacin or ibuprofen therapy for symptomatic post infarction pericarditis. Influence of other pharmacologic agents during early remodelling","volume":"5","author":"Jugdutt","year":"1989","journal-title":"Can. J. Cardiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/0002-9149(86)90729-0","article-title":"Effects of indomethacin on coronary hemodynamics, myocardial metabolism and anginal threshold in coronary artery disease","volume":"57","author":"Pacold","year":"1986","journal-title":"Am. J. Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0002-9149(83)80148-9","article-title":"Scar thinning due to ibuprofen administration after experimental myocardial infarction","volume":"51","author":"Brown","year":"1983","journal-title":"Am. J. Cardiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.amjcard.2007.11.054","article-title":"The antiplatelet effect of six non-steroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers","volume":"101","author":"Gladding","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archinte.1993.00410040045007","article-title":"A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure","volume":"153","author":"Pope","year":"1993","journal-title":"Arch. Intern. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(78)90737-7","article-title":"Treatment of idiopathic orthostatic hypotension (Shy-Drager syndrome) with indomethacin","volume":"1","author":"Kochar","year":"1978","journal-title":"Lancet"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0149-2918(98)80049-0","article-title":"The impact of nonsteroidal anti-inflammatory drugs on hypertension: Alternative analgesics for patients at risk","volume":"20","author":"Ruoff","year":"1998","journal-title":"Clin. Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3109\/07420529709001452","article-title":"Influence of aspirin usage on blood pressure: Dose and administration-time dependencies","volume":"14","author":"Hermida","year":"1997","journal-title":"Chronobiol. Int."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/archinte.158.10.1108","article-title":"NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics","volume":"158","author":"Heerdink","year":"1998","journal-title":"Arch. Intern. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archinte.160.6.777","article-title":"Consumption of NSAIDs and the development of congestive heart failure in elderly patients: An underrecognized public health problem","volume":"160","author":"Page","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2165\/00003495-200363060-00001","article-title":"Nonsteroidal anti-inflammatory drugs and heart failure","volume":"63","author":"Bleumink","year":"2003","journal-title":"Drugs"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/eurheartj\/14.11.1451","article-title":"The role of anticoagulation in the development of pericardial effusion and late tamponade after cardiac surgery","volume":"14","author":"Malouf","year":"1993","journal-title":"Eur. Heart J."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/1466424008096615","article-title":"Fatal haemopericardium and gastrointestinal haemorrhage due to possible interaction of cranberry juice with warfarin","volume":"128","author":"Griffiths","year":"2008","journal-title":"J. R. Soc. Promot. Health"},{"key":"ref_62","first-page":"E144","article-title":"Delayed clinical presentation of hemorrhagic pericardial effusion in a patient receiving warfarin sodium","volume":"36","author":"Hillyard","year":"2007","journal-title":"Am. J. Orthop."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/qjmed\/hcp009","article-title":"Spontaneous haemopericardium with subacute cardiac tamponade in a patient with lung cancer receiving coumadin","volume":"102","author":"Braiteh","year":"2009","journal-title":"QJM"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3949\/ccjm.60.4.336","article-title":"Hemopericardium and cardiac tamponade associated with warfarin therapy","volume":"60","author":"Lee","year":"1993","journal-title":"Cleve Clin. J. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1002\/phar.1602","article-title":"Spontaneous hemopericardium in a patient receiving apixaban therapy: First case report","volume":"35","author":"Sigawy","year":"2015","journal-title":"Pharmacotherapy"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1002\/j.1875-9114.2012.01036.x","article-title":"Hemopericardium in a patient treated with dabigatran etexilate","volume":"32","author":"Barton","year":"2012","journal-title":"Pharmacotherapy"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1345\/aph.1R112","article-title":"Hemopericardium and cardiac tamponade associated with dabigatran use","volume":"46","author":"Dy","year":"2012","journal-title":"Ann. Pharmacother"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1002\/phar.1474","article-title":"Isolated hemopericardium associated with rivaroxaban: First case report","volume":"34","author":"Shivamurthy","year":"2014","journal-title":"Pharmacotherapy"},{"key":"ref_69","first-page":"206","article-title":"Cardiac Tamponade associated with rivaroxaban","volume":"87","author":"Boone","year":"2015","journal-title":"Del. Med. J."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jacc.2003.09.055","article-title":"Day-hospital treatment of acute pericarditis: A management program for outpatient therapy","volume":"43","author":"Imazio","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1053\/j.ajkd.2004.12.005","article-title":"Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population","volume":"45","author":"Huerta","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"ref_72","unstructured":"Whitehouse Station, N.J. (2006). Indocin, (Indomethacin) Prescribing Information, Merck & Co Inc."},{"key":"ref_73","unstructured":"Glasgow, K.Y. (2014). Ibuprofen, Prescribing Information, Amneal Pharmaceuticals."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ki.1983.209","article-title":"A controlled study of the effect of indomethacin in uremic pericarditis","volume":"24","author":"Spector","year":"1983","journal-title":"Kidney Int."},{"key":"ref_75","first-page":"89","article-title":"Uremic pericarditis. Preliminary evaluation of treatment with indomethacin","volume":"72","year":"1979","journal-title":"Med. Clin."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archinte.1975.00330060051006","article-title":"Indomethacin treatment of pericarditis in chronic hemodialysis patients","volume":"135","author":"Minuth","year":"1975","journal-title":"Arch. Intern. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJM199412223312502","article-title":"Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs","volume":"331","author":"Perneger","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/j.ajkd.2004.11.015","article-title":"First United Kingdom Heart and Renal Protection (UK-HARP-I) study: Biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease","volume":"45","author":"Baigent","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"ref_79","unstructured":"Colcrys (2012). (Colchicine) Package Insert, Takeda Pharmaceuticals America Inc."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/B978-0-7020-4086-3.00038-2","article-title":"Nonsteroidal anti-inflammatory drugs exposure and the central nervous system","volume":"119","author":"Auriel","year":"2014","journal-title":"Handb. Clin. Neurol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1365-2125.2012.04387.x","article-title":"CNS effects of indomethacin: Should patients be cautioned about decreased mental alertness and motor coordination?","volume":"75","author":"Hegeman","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4168\/aair.2011.3.1.3","article-title":"Aspirin-exacerbated respiratory disease: Evaluation and management","volume":"3","author":"Lee","year":"2011","journal-title":"Allergy Asthma Immunol. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/CIRCULATIONAHA.107.761064","article-title":"Corticosteroids for recurrent pericarditis: High versus low doses: A nonrandomized observation","volume":"118","author":"Imazio","year":"2008","journal-title":"Circulation"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/9\/2\/17\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:21:10Z","timestamp":1760210470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/9\/2\/17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,23]]},"references-count":83,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,6]]}},"alternative-id":["ph9020017"],"URL":"https:\/\/doi.org\/10.3390\/ph9020017","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,23]]}}}